Morgan AS, Sanderson PE, Borch RF, Tew KD, Niktsu Y, Takayana T, VonHoff DD, Izbicka E, Mangold G, Paul C, Broberg U, Mannervik B, Henner DW and Kauvar LM
Isolinderalactone sensitizes oxaliplatin-resistance colorectal cancer cells through JNK/p38 MAPK signaling pathways
It is truly a medical break-through to be able to provide this glutathione in an oral form that is still absorbed in its most effective form, without the need for needles, clinics, and huge amounts of medical bills
Although there have been conflicting reports on the effects of the incretin class of drugs on the pancreas in animal studies, this is the first study to note such changes in the human pancreas
Clinical efficacy depends on the medication itself, not the manufacturer, so weight loss results match brand-name versions